what is retatrutide called Retatrutide: The New Triple-Agonist Weight Loss Treatment How Does Retatrutide Work? Doctor

This would make it the third major incretin-based obesity drug to reach the market, following semaglutide (Wegovy) and tirzepatide (Zepbound), but the first to use the full triple-agonist mechanism

The popularity of these existing drugs and barriers preventing wider uptake can help shed some light on how orforglipron might change the weight loss treatment landscape

AMG133 (subcutaneous, every 4 weeks) is a monoclonal antibody that was designed to antagonise the GIP receptor and is also linked to two modified GLP-1 peptides that activate the GLP-1 receptor [58]

While these lipid changes are clinically beneficial, GLP-1 agents should complementnot replacestatin therapy for patients requiring significant cholesterol lowering

Acknowledgements This study was supported by grants from JSPS KAKENHI (Grant number JP18K08475) and Manpei Suzuki Diabetes Foundation

A framework that could turn impressive weight loss into true disease modification